Male | 37 | (38.9 %) | |||
Female | 58 | (61.6 %) | |||
Mean (SD) | 61.3 | (± 19.5) | |||
Present | 57 | (60 %) | |||
Not present | 38 | (40 %) | |||
Reduced mobility | 38 | (40 %) | 0.6 | 0.5 | 0.7 |
Previous PE | 8 | (8.4 %) | 0.7 | 0.2 | 0.9 |
Oral contraceptives | 7 | (7.4 %) | 0.5 | 0.4 | 0.2 |
Known malignancy | 6 | (6.3 %) | 0.09 | 0.2 | 0.3 |
Proven GVT | 6 | (6.3 %) | 0.9 | 0.7 | 0.1 |
Congestive heart failure | 5 | (5.3 %) | 0.5 | 0.3 | 0.7 |
COPD | 4 | (4.2 %) | 0.5 | 0.9 | 0.07 |
No comorbidities | 37 | (38.9 %) | |||
1 | 51 | (53.7 %) | |||
2 | 5 | (5.3 %) | |||
3 | 2 | (2.1 %) |
Pleural effusion | Mean PI size |
---|---|
Not present | 14.3 cm3 (± 17.8 cm3) |
Present | 34.5 cm3 (± 50.5 cm3) |